信源企業集團(01748.HK):瑞豐出售1.16億股公司股份予環宇國際
格隆匯8月12日丨信源企業集團(01748.HK)公佈,公司董事會獲悉,於2020年8月12日,香港瑞豐物產國際有限公司與環宇國際科技(香港)有限公司訂立一項買賣協議,據此,瑞豐已同意出售而環宇國際已同意購買1.16億股公司股份(相當於公司於本公告日期已發行股本總額約26.36%),代價為1.62億港元。
待轉讓事項完成後,瑞豐將不再持有公司任何股份,因此,瑞豐將不再為公司的主要股東。緊隨轉讓事項完成後,環宇國際將持有公司已發行股本總額約26.36%,並將成為公司的主要股東及關連人士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.